Key result
Acetylcholinesterase inhibitors may improve autonomic and cardiac function in acute myocardial infarction and heart failure, though their exact clinical role remains unclear.
Why the study?
Despite potential clinical benefits for cardiovascular disease patients, the role of acetylcholinesterase inhibitors in acute myocardial infarction and heart failure remediation remains unclear.
Do acetylcholinesterase inhibitors improve cardiac outcomes in acute myocardial infarction and heart failure?
Design
Review
Authors
Loading...
Hypothesis-generating for cholinergic modulation in AMI and HF; randomized trials needed before any clinical role.
Do acetylcholinesterase inhibitors improve cardiac outcomes in acute myocardial infarction and heart failure?
Acetylcholinesterase inhibitors represent a potential therapeutic approach to moderate parasympathetic activity and improve cardiac function in acute myocardial infarction and heart failure.
Khuanjing et al. (2019) conducted a review in Acute myocardial infarction and heart failure. Acetylcholinesterase inhibitors was evaluated. Acetylcholinesterase inhibitors may improve autonomic and cardiac function in acute myocardial infarction and heart failure, though their exact clinical role remains unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: